Office of Research & Development |
|
Project Number: I01BX002301-05
Title: Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival
Principal Investigator: Ann Richmond
FY 2019 Funding Amount: $207,093
Location: Nashville, TN Congressional District Code: 5 Research Service: Biomedical Laboratory R&D Project Period: January 2018 - December 2021 |
Abstract: View abstract and other project information on NIH RePORTER Go To NIH RePORTER ⇑ |